A型与B型肉毒杆菌毒素治疗腋窝多汗症：一项为期6个月的病例系列观察研究 - Suppr | 超能文献

Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.

作者信息

Frasson Emma, Brigo Francesco, Acler Michele, Didonè Giuseppe, Vicentini Silvana, Bertolasi Laura

机构信息

Department of Neurology, Cittadella Hospital, Padua, Italy.

出版信息

Arch Dermatol. 2011 Jan;147(1):122-3. doi: 10.1001/archdermatol.2010.408.

DOI:10.1001/archdermatol.2010.408

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.A型与B型肉毒杆菌毒素治疗腋窝多汗症：一项为期6个月的病例系列观察研究

Arch Dermatol. 2011 Jan;147(1):122-3. doi: 10.1001/archdermatol.2010.408.

2

Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.肉毒杆菌素与丽舒妥治疗原发性腋窝多汗症的同患者前瞻性比较及文献综述

J Drugs Dermatol. 2011 Sep;10(9):1013-5.

3

Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.A型和 B 型肉毒毒素可改善腋窝和手掌多汗症患者的生活质量。

Acta Derm Venereol. 2013 May;93(3):335-9. doi: 10.2340/00015555-1464.

4

Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.A型肉毒杆菌毒素治疗双侧原发性腋窝多汗症：随机、平行组、双盲、安慰剂对照试验。

BMJ. 2001 Sep 15;323(7313):596-9. doi: 10.1136/bmj.323.7313.596.

5

Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.注射B型肉毒毒素（Myobloc）治疗手掌多汗症后的全身不良反应。

Arch Dermatol. 2003 Feb;139(2):226-7. doi: 10.1001/archderm.139.2.226.

6

Treatment of axillary hyperhidrosis with botulinum-A toxin.用A型肉毒毒素治疗腋窝多汗症。

Int J Dermatol. 2002 Jul;41(7):428-30. doi: 10.1046/j.1365-4362.2002.01448.x.

7

Writer's block: "texting" impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis.书写障碍：A型肉毒毒素治疗手掌多汗症的并发症——“短信书写”功能受损

Arch Dermatol. 2011 Jun;147(6):752. doi: 10.1001/archdermatol.2011.143.

8

Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.肉毒杆菌素B型（Myobloc）治疗腋窝多汗症安全性和有效性的初步研究。

Int J Dermatol. 2005 May;44(5):418-24. doi: 10.1111/j.1365-4632.2004.02531.x.

9

Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?用于帕金森病流涎症的A型和B型肉毒杆菌毒素：是否需要更换治疗方法？

J Rehabil Med. 2008 Nov;40(10):882-3. doi: 10.2340/16501977-0257.

10

How to save botulinum toxin A in the treatment of focal axillary hyperhidrosis.如何保存A型肉毒杆菌毒素用于治疗局限性腋窝多汗症。

Dermatology. 2006;213(4):356. doi: 10.1159/000096204.

引用本文的文献

1

Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review.肉毒毒素 B 在局限性多汗症中的疗效和安全性：叙事性综述。

Toxins (Basel). 2023 Feb 11;15(2):147. doi: 10.3390/toxins15020147.

2

[Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].[多汗症——病因发病机制、诊断、临床症状及治疗]

Hautarzt. 2018 Oct;69(10):857-869. doi: 10.1007/s00105-018-4265-8.